Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis

Human Immunology

Volumn 63, Issue 9, 2002, Pages 758-764

  Verbruggen, Leon A ^a,b   Versaen, Hendrik ^b   Rebmann, Vera ^d   Duquet, William ^c   De Cock, Seija ^a   Grosse Wilde, Hans ^d   Demanet, Christian ^b  

^a Rheumatology Unit   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c FREE UNIVERSITY OF BRUSSELS   (Belgium)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Disease activity; Rheumatoid arthritis; Shared epitope; Soluble HLA DR; Therapy

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEREDITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; EPITOPES; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; SOLUBILITY;

EID: 0036727189     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00431-7     Document Type: Article

References (33)

1. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay
2. Detection of soluble HLA
3. Soluble HLA: A review of the literature
4. A preliminary study of serum class II levels in healthy individuals and bone-marrow transplant patients
5. Soluble HLA-I in rheumatic diseases
6. Soluble HLA in human body fluids
7. Soluble HLA class I and class II concentrations in commercial immunoglobulin preparations
8. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations
9. Immunologically active proteins in intravenous immunoglobulin
10. Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions
11. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity
12. Soluble HLA class I antigens in patients with systemic lupus erythematosus
13. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: Correlation with anti-DNA antibodies and leukopenia
14. Soluble HLA class I and class II antigens in patients with multiple sclerosis
15. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes
16. High concentration of soluble HLA-DR in the synovial fluid: Generation and significance in "rheumatoid-like" inflammatory joint diseases
17. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis
18. The effect of HLA-DRB 1 disease susceptibility markers on the expression of RA
19. Association of (Q)R/KRAA positive HLA-DRB 1 alleles with disease progression in early active and severe rheumatoid arthritis
20. Can HLA-DRB1 typing have prognostic value in patients with undifferentiated chronic arthritis?
21. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
22. Report on the EULAR standing committee on international clinical studies including therapeutic trials
23. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization
24. Rheumatoid factor
25. Serum soluble HLA-DR antigens in autoimmune hepatitis
26. The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus- host disease
27. The lysosomotropic amines, chloroquine and hydroxychloroquine: A potentially novel therapy for graft-versus-host disease
28. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production
29. 2 suppressed IL-15-mediated human NK cell function through down-regulation of commonγ-chain
30. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs
31. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis
32. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone
33. HLA class III region and susceptibility to rheumatoid arthritis